Abstract
Diabetes is a common metabolic disorder observed worldwide; therefore, the increase in the prevalence of diabetes must be ascribed to changes in lifestyle. Dietary intervention and lifestyle modification are highly effective means to prevent and treat obesity and/or diabetes. Gut motility disturbances exist in a number of patients with diabetes, resulting in malnutrition and weight loss. Therefore, the diet for diabetes patients should be consistent with general public health nutrition principles, i.e., a fat-reduced, fiber-rich, and low-energy-density carbohydrate-rich diet. This chapter provides an overview of these agents and their implications in order to provide more information on the treatment of diet-related disorders in diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 5HT-4:
-
5-HydroxyTryptamine Receptor 4
- BMI:
-
Body Mass Index
- DCCT:
-
Diabetes Control and Complications Trial
- GERD:
-
Gastroesophageal Reflux Disease
- GI:
-
Gastrointestinal
- PI3K:
-
Phosphatidylinositol 3-Kinase
- TTG:
-
Tissue Transglutaminase Test
- WHO:
-
World Health Organization
References
Abell T, Lou J, Tabbaa M, Batista O, Malinowski S, Al Juburi A. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. JPEN J Parenter Enteral Nutr. 2003;27:277–81.
Abell TL, Bernstein RK, Cutts T, Farrugia G, Forster J, Hasler WL, McCallum RW, Olden KW, Parkman HP, Parrish CR, Pasricha PJ, Prather CM, Soffer EE, Twillman R, Vinik AI. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil. 2006;18:263–83.
Ambizas EM, Ginzburg R. Lubiprostone: a chloride channel activator for treatment of chronic constipation. Ann Pharmacother. 2007;41:957–64.
Anitha M, Gondha C, Sutliff R, Parsadanian A, Mwangi S, Sitaraman SV, Srinivasan S. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest. 2006;116:344–56.
Boyle PJ, Zrebiec J. Physiological and behavioral aspects of glycemic control and hypoglycemia in diabetes. South Med J. 2007;100:175–82.
Bromer MQ, Friedenberg F, Miller LS, Fisher RS, Swartz K, Parkman HP. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc. 2005;61:833–9.
Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15 000 adults. Arch Intern Med. 2001a;161:1989–96.
Bytzer P, Talley NJ, Jones MP, Horowitz M. Oral hypoglycaemic drugs and gastrointestinal symptoms in diabetes mellitus. Aliment Pharmacol Ther. 2001b;15:137–42.
Camilleri M. Clinical practice: Diabetic gastroparesis. N Engl J Med. 2007;356:820–9.
Campbell L, Rossner S. Management of obesity in patients with Type 2 diabetes. Diabet Med. 2001;18:345–54.
Campfield LA, Smith FJ. Blood glucose dynamics and control of meal initiation: a pattern detection and recognition theory. Physiol. 2003;88:25–58.
Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17:961–9.
Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995;122:481–6.
Darwazeh AM. Mixed salivary glucose levels and candidal carriage in patients with diabetes mellitus. J Oral Path Med. 1991;20:280–3.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;977–86.
Garner DM. The effects of starvation on behavior: implications for dieting and eating disorders. Healthy Weight J. 1998;21:68–72.
Gottesman I. Managing obesity and glycemic control in insulin-using patients: clinical relevance and practice recommendations. Diabetes Res Clin Pract. 2004;65:17–22.
Greenberg L. Case management implications of celiac disease. Prof Case Manag. 2008;13:211–7.
Grey M, Berry D. Coping skills training and problem solving in diabetes. Curr Diab Rep. 2004;4:126–31.
Gumbiner B. Treating obesity in Type 2 diabetes: calories, composition and control. Diabetes Care. 1999;22:886–8.
Han TS, Feskens EJ, Lean ME, Seidell JC. Associations of body composition with type 2 diabetes mellitus. Diabet Med. 1998;15:129–35.
Heilbronn LK, Noakes M, Clifton PM. Effect of energy restriction, weight loss, and diet composition on plasma lipids and glucose in patients with type 2 diabetes. Diabetes Care. 1999;22:889–95.
Hill ID, Dirks MH, Liptak GS, Colletti RB, Fasano A, Guandalini S, Hoffenberg EJ, Horvath K, Murray JA, Pivor M, Seidman EG. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Pediatr Gastroenterol Nutr. 2005;40:1–19.
Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke K. Nitrosative stress, uric Acid, and peripheral nerve function in early type 1 diabetes. Diabetes. 2002;51:2817–25.
Horvath VJ, Vittal H, Lorincz A, Chen H, Almeida Porada G, Redelman D, Ordog T. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology. 2006;130:759–70.
Horowitz M, Fraser RJ. Gastroparesis: diagnosis and management. Scand J Gastroenterol Suppl. 1995;213:7–16.
Jones MP. Access options for withdrawn motility-modifying agents. Am J Gastroenterol. 2002;97:2184–8.
Kinekawa F, Kubo F, Matsuda K, Fujita Y, Tomita T, Uchida Y, Nishioka M. Relationship between esophageal dysfunction and neuropathy in diabetic patients. Am J Gastroenterol. 2001;96:2026–32.
Kuo P, Rayner CK, Jones KL, Horowitz M. Pathophysiology and management of diabetic gastropathy: a guide for endocrinologists. Drugs. 2007;67:1671–87.
Lata PF, Pigarelli DL. Chronic metoclopramide therapy for diabetic gastroparesis. Ann Pharmacother. 2003;37:122–6.
Leinninger GM, Edwards JL, Lipshaw MJ, Feldman EL. Mechanisms of disease: mitochondria as new therapeutic targets in diabetic neuropathy. Nat Clin Pract Neurol. 2006;2:620–8.
Leventhal H, Cameron L. Behavioural theories and the problem of compliance. Patient Educ Couns. 1987;10:117–38.
Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjo È stro Èm L. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes. 1989;13:413–23.
Lysy J, Israeli E, Strauss Liviatan N, Goldin E. Relationship between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients. Neurogastroenterol Motil. 2006;18:433–40.
Maleki D, Locke GR 3rd, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, Melton LJ 3rd. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808–16.
Mishra GD, Carrigan G, Brown WJ, Barnett AG, Dobson AJ. Short-term weight change and the incidence of diabetes in midlife: Results from the Australian Longitudinal Study on Women’s Health. Diabetes Care. 2007;30:1418–24.
National Institutes of Health, National Heart Lung and Blood Institute. Clinical guidelines for the identification, evaluation and treatment of overweight and obesity in adults: the evidence report. Bethesda: US Department of Health and Human Services, Public Health Service, NIH, NHLBI; 1998.
Ohlson LO, Larsson B, Sva È rdsudd K, Welin L, Eriksson H, Whilhelmsen L. The influence of body fat distribution on the incidence of diabetes mellitus: 13 5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34:1055–8.
Plodkowski RA, St Jeor ST. Medical nutrition therapy for the treatment of obesity. Endocrinol Metab Clin North Am. 2003;32:935–65.
Report of a WHO consultation on obesity. Obesity: preventing and managing the global epidemic. Geneva. 3–5 June; 1997.
Rayner CK, Horowitz M. New management approaches for gastroparesis. Nat Clin Pract Gastroenterol Hepatol. 2005;2:454–62; quiz 493.
Rayner CK, Horowitz M. Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited. J Clin Invest. 2006;116:299–302.
Sellin JH, Chang EB. Therapy Insight: gastrointestinal complications of diabetesȓpathophysiology and management. Nat Clin Pract Gastroenterol Hepatol. 2008;5:162–71.
Shakil A, Church RJ, Rao SS. Gastrointestinal complications of diabetes. Am Fam Physician. 2008;77:1697–702.
Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol. 2003;98:264–71.
UK Prospective Diabetes Study (UKPDS). Group. Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients (UKPDS 7). Metabolism. 1990;39:905–12.
Watkins PJ, Buxton Thomas MS, Howard ER. Long-term outcome after gastrectomy for intractable diabetic gastroparesis. Diabet Med. 2003;20:58–63.
Wing RR, Hill JO. Successful weight loss maintenance. Annu Rev Nutr. 2001;21:323–41.
Acknowledgments
The authors would like to acknowledge Dr. Inui and Dr. Asakawa for their dedicated work, who planned the studyand provided creative suggestions for improving the analysis. Also all authors contributed to the review and writing of the manuscript will be highly appreciated.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Li, YX., Cheng, KC., Asakawa, A., Inui, A. (2011). Treatment of Diet-Related Disorders in Adult Diabetes. In: Preedy, V., Watson, R., Martin, C. (eds) Handbook of Behavior, Food and Nutrition. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92271-3_211
Download citation
DOI: https://doi.org/10.1007/978-0-387-92271-3_211
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-92270-6
Online ISBN: 978-0-387-92271-3
eBook Packages: MedicineMedicine (R0)